Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
XuanZhu Pharma
company
About
XuanZhu Pharma is a biopharmaceutical company that focuses on drug research and development.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥610.50M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 251 - 500
- Operating Status
- Active
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥610.50M
XuanZhu Pharma has raised a total of
¥610.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 31, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | Series B | ¥610.50M | 6 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
6
XuanZhu Pharma is funded by 6 investors.
Jinjiang Xuanhong Equity Investment
and BOC Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
Financial Holding Group
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
